Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001140361-18-000538

Options or other derivatives

  • Director acquired 25,000 shares (grant or award)
  • Director acquired 1,184 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
KIRK RANDAL J Director 2017-12-29 Grant or award · Option to Purchase Common Stock +25,000 25,000 D: show line 1 in the form
KIRK RANDAL J Director 2017-12-29 Other acquisition · Series 1 Preferred Stock +1,184 119,644 I: show line 2 in the form
Loading xslF345X03/doc1.xml…